跳至主要内容
临床试验/NCT07664943
NCT07664943尚未招募不适用

The iD2: A Smart Eye Drop Cap Monitor for Eye Drop Adherence

Universal Adherence LLC0 个研究点目标入组 100 人开始时间: 2026年9月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
100

研究概览

简要总结

Most patients with glaucoma use eye drops to lower their intraocular pressure. However, poor adherence to prescribed eye drop regimens can lead to significant loss of vision-related quality of life. This study will test the iDrop Device (iD2), a device-on-cap electronic platform monitor designed to accurately track when a research participant removes an eye drop bottle cap, wirelessly communicate usage data to a database accessible to researchers, and send on-demand alerts when a medication is due. A device capable of tracking eye drop usage and sending dosage alerts will test the hypothesis that electronic reminders improve medication adherence and help research subjects improve their eye drop taking behavior. While our primary focus is on glaucoma adherence, this device could also benefit those with other chronic eye conditions requiring regular eye drop treatment, such as dry eye, corneal endothelial disease, eye infections, and uveitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Taking at least one glaucoma drop daily
  • A history of poor adherence when taking glaucoma eye drops. This is determined as an answer of 80% or less for the following question: "Over the past month, what percentage of your drops do you think you took correctly?"
  • Owns a functioning smart phone with Bluetooth and cellular connectivity

排除标准

  • Advanced cognitive impairment
  • Current or expected pregnancy during the study.

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

The iD2: A Smart Eye Drop Cap Monitor for Eye Drop... | 临床试验